In the field of reproductive health, ovarian health has long been a key focus for researchers and women preparing for pregnancy. As women age, the natural decline in ovarian function directly impacts fertility. Juvenex Reco18, developed based on multiple scientific studies, offers an innovative nutritional solution to support and improve ovarian health.
Scientific Foundation and Research Evidence
The development of Juvenex Reco18 is grounded in research published in the SCI-indexed journal Frontiers in Endocrinology. This study thoroughly explains the mechanism of action of the product’s core ingredients on ovarian health, confirming their ability to effectively promote granulosa cell proliferation and reduce follicular atresia. In rigorous animal model experiments, researchers observed significant improvements in hormone levels related to ovarian health:
– Follicle-stimulating hormone (FSH) decreased by 56%
– Estradiol (E2) increased by 80%
Clinical Study Results
Through clinical observations conducted in multiple hospitals and medical centers, researchers collected authentic effectiveness data from users. The results showed that women taking Juvenex Reco18 demonstrated improvements across several fertility indicators related to ovarian health. Notably, the treatment group outperformed the control group in high-quality blastocyst rate and clinical pregnancy success rate.
For women with poor embryo quality, the following improvements were observed after 45 days of use:
– FSH levels decreased by 17.7%
– Total number of oocytes retrieved increased by 29.5%
– Number of high-quality embryos increased by 113%
Safety Assurance and Quality Standards
Juvenex Reco18 is produced in strict compliance with international and industry standards. It meets U.S. FDA ingredient safety requirements, holds ISO quality management certification, and has passed comprehensive safety and efficacy testing by SGS and Intertek.
Test results show no hormones, heavy metals, or other harmful substances. Long-term use has no adverse effects on body weight or blood markers, fully safe for continuous use.
Additionally, all vitamins and minerals added to the product strictly comply with the nutritional recommendations and regulatory standards set by international authorities for women preparing for pregnancy and pregnant women.
Personalized Dosing Recommendations
Tailored dosing is recommended based on individual ovarian reserve status:
– Normal ovarian reserve (under 35 years old, AMH > 2.0): 4 capsules daily
– Diminished ovarian reserve (35–40 years old, AMH 0.8–2.0): 4–8 capsules daily
– Poor ovarian function (over 40 years old, AMH < 0.8): 8 capsules daily
Conclusion
Through its unique combination of active ingredients, Juvenex Reco18 supports women’s ovarian health on multiple levels: promoting granulosa cell proliferation, optimizing hormonal balance, and reducing follicular atresia. For modern women who care about ovarian health and seek evidence-based preparation for pregnancy, Juvenex Reco18 represents a professional and reliable choice.